Sunil Tomar

Sunil Tomar is a Principal Scientist with extensive experience in analytical development for cell and gene therapies, particularly in CAR T-cell platforms. They have led innovative research projects at institutions such as Genentech, the University of Michigan, and Poseida Therapeutics, focusing on immunology and complex assay development. Sunil has a proven track record in managing cross-functional teams, ensuring assay transfer and qualification, and collaborating with regulatory bodies to align strategies with FDA/EMA expectations. They hold a PhD in Biomedical Sciences from the University of South Carolina and a B.Tech. in Biotechnology from GGS Indraprastha University.